Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/2002
04/03/2002CN1342690A Polypeptide-nerve signal conducting protein 22.11 and polynucleotide for coding it
04/03/2002CN1342689A Polypeptide-apolipoprotein 28.17 and polynucleotide for coding it
04/03/2002CN1342688A Polypeptide-ribosomal protein L5-10.01 and polynucleotide for coding it
04/03/2002CN1342687A Polypeptide-ribosomal protein L2-8.8 and polynucleotide for coding it
04/03/2002CN1342686A Polypeptide-human kidney-specific protein 35.53 and polynucleotide for cocing it
04/03/2002CN1342685A Polypeptide-human trypsin inhibitor 10.12 and polynucleotide for coding it
04/03/2002CN1342684A Polypeptide-neurodevelopment associated protein 19.25 and polynucleotide for coding it
04/03/2002CN1342683A Polypeptide-human zinc finger protein 192-22 and polynucleotide for coding it
04/03/2002CN1342682A Polypeptide-human zinc finger protein 14.96 and polynucleotide for coding it
04/03/2002CN1342681A Polypeptide-human zinc finger protein 10.45 and polynucleotide for coding it
04/03/2002CN1342680A Polypeptide-brain plasticity associated protein 52.36 and polynucleotide for coding it
04/03/2002CN1342679A Polypeptide-neurodevelopment regulatory protein 37.95 and polynucleotide for coding it
04/03/2002CN1342677A Polypeptide-insulin-like growth factor binding 10.45 and polynucleotide for coding it
04/03/2002CN1342676A Polypeptide-human ring finge rprotein 31.57 and polynucleotide for coding it
04/03/2002CN1342675A Polypeptide-ribosomal protein S11-17.49 and polynucleotide for coding it
04/03/2002CN1342672A Polypeptide-human cell signal/architecture protein 11.22 and polynucleotide for coding it
04/03/2002CN1342671A Polypeptide-protein 111.11 containing homeobox domain and aconitase characteristic sequence and polynucleotide for coding it
04/03/2002CN1342670A Polypeptide-dipeptaminopeptidase IV associated protein (DPPX)47.41 and polynucleotide for coding it
04/03/2002CN1342669A Polypeptide-Na ion and H ion exchanging protein 6 (NHE-6) 39.38 and polynucleotide for coding it
04/03/2002CN1342668A Polypeptide-F actin binding factor 32.78 and polynucleotide for coding it
04/03/2002CN1342667A Polypeptide-zinc iron transporter 42.57 and polynucleotide for coding it
04/03/2002CN1342666A Polypeptide-protein 32.67 containing hemeobox domain and aconitase characteristic sequence and polynucleotide for coding it
04/03/2002CN1342665A Polypeptide-channel protein hAQP 14.74 and polynucleotide for coding it
04/03/2002CN1342664A Polypeptide-G-beta protein 14.08 containing WD duplicate domain and polynucleotide for coding it
04/03/2002CN1342663A Polypeptide-semaphorin protein B28.71 and polynucleotide for coding it
04/03/2002CN1342661A Polypeptide-protein Rab36-27.61 and polynucleotide for coding it
04/03/2002CN1342660A Polypeptide-GTP binder 42.57 and polynucleotide for coding it
04/03/2002CN1342659A Polypeptide-integrin 15.95 and polynucleotide for coding it
04/03/2002CN1342658A Polypeptide-PO protein 26.07 and polynucleotide for coding it
04/02/2002US6365717 Peptides and nucleic acid sequences related to the Epstein Barr virus
04/02/2002US6365716 Binds to epitope of polypeptide having defined amino acid sequence; antitumor agents
04/02/2002US6365715 Human cardiac/brain tolloid-like protein
04/02/2002US6365714 Amino acid sequence of a polypeptide; antiinflammatory agents; antiproliferative agents; antiapoptotic agents
04/02/2002US6365712 Isolated soluble cd antigen; diagnosis and treatment of related disorders
04/02/2002US6365402 Growth differentiation factor-9
04/02/2002US6365395 Process for removing protein aggregates and virus from a protein solution
04/02/2002US6365392 Amino acid sequences; anthelmintics; nematocides; vaccines; for veterinary medicine
04/02/2002US6365391 Isolated human serine protease, nucleic acid molecules encoding human serine protease, and uses thereof
04/02/2002US6365389 Human protein kinase H2LAU20
04/02/2002US6365371 Amino acid sequence; diagnosis, prevention and treatment of cancer, reproductive disorders, immune disorders, and developmental disorders; anticarcinogenic agents
04/02/2002US6365370 Dna which codes for 5-hydroxytryptamine 3-c protein of defined amino acid sequence; antiinflammatory agents; treatment of huntington's disease, alzheimer's disease and others
04/02/2002US6365359 Identifying prp pharmacore by determining functional residues of protein involved in complex interactions, developing three dimensional structures, comparing them with other compounds and identifying compounds consistent with binding to protein
04/02/2002US6365358 Polypeptide of defined amino acid sequence; diagnosis, prevention and treatment of cancer, developmental, autoimmune and nervous system disorders; anticarcinogenic agents; antiinflammatory agents
04/02/2002US6365357 Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
04/02/2002US6365161 Molecular complex comprising two or more protein or peptide binding specificities for component on surface of antigen presenting cell, having at least one antigen linked thereto, wherein component mediates internalization of complex
04/02/2002US6365159 Spo-rel
04/02/2002US6365158 Immunizing avian host with purified recombinant fusion protein comprising non-toxin protein sequence and portion of clostridium difficile toxin b sequence so as to generate neutralizing antitoxin
04/02/2002US6365157 Angiogenesis inhibitors; antitumor agents
04/02/2002US6365156 Contacting mucosal membrane of animal with chimeric molecule comprising viral-specific ligand and bacterial-specific ligand which is specific for bacteria colonizing membrane
04/02/2002US6365155 Monoclonal antibody, antibody fragment, mixture or derivative thereof, which binds to ancrod and inhibits its activity
04/02/2002US6365154 Tie2 agonist antibodies
04/02/2002CA2147875C Crf binding protein
04/02/2002CA1341353C Viral vector and recombinant dna coding for a glycoprotein of the aids (virus) causative agent, cellular culture infected by this vector, manufacturing method for the glycoprotein, and resulting glycoprotein, vaccine and antibody
03/2002
03/29/2002CA2340303A1 Rna-binding protein
03/28/2002WO2002025285A1 Prognostic indicator
03/28/2002WO2002024961A1 In vitro assay for measuring the immunogenicity of a vaccine
03/28/2002WO2002024924A2 Protein phosphatases
03/28/2002WO2002024923A1 Polypeptide having phospholipase a2 actiivty
03/28/2002WO2002024920A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/28/2002WO2002024914A1 Modification of plant cell wall component and method of regulating development differentiation
03/28/2002WO2002024912A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
03/28/2002WO2002024910A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
03/28/2002WO2002024909A2 Receptor nucleic acids and polypeptides
03/28/2002WO2002024907A2 G-protein coupled receptor hfrbn63
03/28/2002WO2002024892A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
03/28/2002WO2002024891A2 B7-like molecules and uses thereof
03/28/2002WO2002024888A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/28/2002WO2002024883A2 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
03/28/2002WO2002024752A2 Monoclonal antibodies against lipid structures different from the double layer of cell membranes for defining physiological states in different cell types and detecting anti lipid particle antibodies in human beings and/or animals suffering from certain antiphospholipid antibody-related diseases
03/28/2002WO2002024749A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
03/28/2002WO2002024748A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/28/2002WO2002024733A2 Human polynucleotides and polypeptides encoded thereby
03/28/2002WO2002024727A2 New inhibitors of iapp fibril formation and uses thereof
03/28/2002WO2002024223A2 Prevention and treatment of streptococcal and staphylococcal infection
03/28/2002WO2002024217A1 Use of il-8 protein modulators in the treatment of viral infections
03/28/2002WO2002024149A2 Immunogen comprising ligand bound hiv envelpe protein
03/28/2002WO2002011743A3 Treatment of prostate cancer
03/28/2002WO2001096601A3 Neurotransmission disorders
03/28/2002WO2001090153A8 Reagents for cell selection and methods of use
03/28/2002WO2001088538A8 Compositions and methods for epitope mapping
03/28/2002WO2001085772A3 Virulence genes, proteins, and their use
03/28/2002WO2001085770A3 Sentinel virus ii
03/28/2002WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents
03/28/2002WO2001080880A3 Apoptotic agents
03/28/2002WO2001078653A3 Graft rejection inhibition with ccr2 inhibitors
03/28/2002WO2001077150A3 Serine-threonine kinase
03/28/2002WO2001074859A3 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
03/28/2002WO2001070977A3 Fibroblast growth factor receptor-like molecules and uses thereof
03/28/2002WO2001070777A3 Leafy cotyledon2 genes and their uses
03/28/2002WO2001066124A3 Composition for the treatment of heart failure
03/28/2002WO2001066107A3 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
03/28/2002WO2001062925A3 103p2d6: tissue specific protein highly expressed in various cancers
03/28/2002WO2001062793A3 Estrogen receptor beta variants and methods of detection thereof
03/28/2002WO2001057224A3 Allene oxide cyclase gene and use thereof for producing jasmonic acid
03/28/2002WO2001057194A3 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
03/28/2002WO2001057182A3 Nucleic acids, proteins, and antibodies
03/28/2002WO2001055356A3 Human protein kinases and protein kinase-like enzymes
03/28/2002WO2001051642A3 Dna modification proteins
03/28/2002WO2001049729A3 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use
03/28/2002WO2001038486A3 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies